Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
C$0.08
-11.8%
C$0.08
C$0.07
C$0.18
C$42.03M1.22106,698 shs125,751 shs
Fura Gems Inc. stock logo
FURA
Fura Gems
C$0.15
-3.3%
C$0.14
C$0.05
C$0.21
C$39.45M1.06128,388 shs10,000 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
$0.12
$0.07
$1.52
$2.61M1.973.22 million shs1.57 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
-6.25%0.00%-11.76%-21.05%-34.78%
Fura Gems Inc. stock logo
FURA
Fura Gems
0.00%0.00%0.00%0.00%0.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+3.68%-3.43%-44.20%-50.84%+7,599,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
N/AN/AN/AN/AN/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
N/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
C$21.77K1,930.89C$0.00 per share17.14C$0.23 per share0.33
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AC$0.01 per share29.00C$0.02 per shareN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.19N/AN/A$0.12 per share0.63

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
C$1.09M-C$0.01N/AN/A1,100.59%0.89%-2.44%7/2/2024 (Estimated)
Fura Gems Inc. stock logo
FURA
Fura Gems
-C$29.04M-C$0.12N/AN/AN/A-495.84%-38.02%N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.09N/A-65.46%-150.14%-53.48%N/A

Latest NBY, AVL, BEM, and FURA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
N/AN/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
2.36
0.97
2.13
Fura Gems Inc. stock logo
FURA
Fura Gems
1,870.18
0.26
0.12
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
N/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
21.56%
Fura Gems Inc. stock logo
FURA
Fura Gems
65.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avalon Advanced Materials Inc. stock logo
AVL
Avalon Advanced Materials
9560.37 millionN/ANot Optionable
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A272.04 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

NBY, AVL, BEM, and FURA Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avalon Advanced Materials logo

Avalon Advanced Materials

TSE:AVL
Avalon Advanced Materials Inc., together with its subsidiaries, engages in the acquisition, exploration, evaluation, and development of rare metal and mineral properties primarily in Canada. The company focuses on exploring lithium, tantalum, cesium, indium, gallium, germanium, tin, yttrium, and zirconium deposits, as well as rare earth elements. Its flagship project is the 100% owned Separation Rapids Lithium Project consisting of nineteen mineral claims and one mining lease covering an area of approximately 4,414 hectares located in the Paterson Lake Area, Kenora Mining Division, Ontario. The company was formerly known as Avalon Rare Metals Inc. and changed its name to Avalon Advanced Materials Inc. in February 2016. Avalon Advanced Materials Inc. is headquartered in Toronto, Canada.
Fura Gems logo

Fura Gems

CVE:FURA
Fura Gems Inc., a gemstone mining and marketing company, engages in the mining, exploration and acquisition of gemstone licenses in Barbados, the British Virgin Islands, Colombia, Dubai, India, Mozambique, Madagascar, and Australia. It holds a 100% interests in four ruby licenses in the Montepuez district of Cabo Delgado province in Mozambique; and a 76% interests in the Coscuez license that covers an area of covers an area of 46 hectares in San Pablo de Borbur, Boyacá District of Colombia. The company also holds a 100% interests in two mining permits and three mining licenses in the sapphire mining project located in Queensland, Australia; and owns sapphire licenses in Madagascar. The company was formerly known as Fura Emeralds Inc. and changed its name to Fura Gems Inc. in April 2017. Fura Gems Inc. was incorporated in 2006 and is headquartered in Toronto, Canada. Fura Gems Inc. operates as a subsidiary of Lord of Seven Hills Holdings FZE.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.